Cheshire veterinary drugs giant Dechra Pharmaceuticals announced that Tony Griffin will step down as an executive director of the company after 12 years of service, with…

Cheshire veterinary drugs giant Dechra Pharmaceuticals reported revenue growth of 5.5% to £761.5 million for the year ended June 30, 2023, and said underlying operating…

By Mark McSherry Swedish private equity firm EQT and the Abu Dhabi Investment Authority (ADIA) have agreed a deal to buy Cheshire veterinary drugs giant…

Shares of Dechra Pharmaceuticals, the Cheshire-based veterinary drugs giant, fell about 10% on Monday after it published a trading update for the financial year ending June 30,…

Dechra Pharmaceuticals, the Cheshire-based international veterinary drugs giant, said on Thursday it has extended the deadline for a possible £4.63 billion all-cash takeover offer from Swedish…

Shares of Cheshire-based international veterinary drugs giant Dechra Pharmaceuticals rose about 35% to around £37.50 on Friday after it said late on Thursday it has entered…

Cheshire-based international veterinary drugs giant Dechra Pharmaceuticals said late on Thursday it has entered into discussions with Swedish private equity firm EQT over a possible £4.63 billion…

Shares of Chesire-based international veterinary drugs giant Dechra Pharmaceuticals fell about 15% after it reported “unpredictable” trading patterns and said it expects full year underlying operating…

Chesire-based international veterinary drugs giant Dechra Pharmaceuticals is currently a contender to be relegated from the FTSE 100, according to Hargreaves Lansdown. The FTSE All…

Chesire-based international veterinary drugs giant Dechra Pharmaceuticals announced its revenue grew 13.8% to £681.8 million and underlying operating profit increased 9.4% to £174.3 million in…

Chesire-based international veterinary drugs giant Dechra Pharmaceuticals announced it has acquired Med-Pharmex, a veterinary pharmaceutical manufacturer based in Pomona, California, for £221.5 million. “The acquisition will…

Chesire-based international veterinary drugs giant Dechra Pharmaceuticals announced it has agreed to acquire US-based Piedmont Animal Health, Inc for £175 million in cash. Dechra also announced…

Chesire-based international veterinary drugs giant Dechra Pharmaceuticals said on Monday its revenue rose 10.9% to £332.4 million in the six months to December 31, 2021, while profit…

Chesire-based international veterinary drugs giant Dechra Pharmaceuticals said on Tuesday it agreed terms with Anivive Lifesciences Inc to acquire the worldwide rights to verdinexor, a novel…

Chesire-based international veterinary drugs giant Dechra Pharmaceuticals announced that following a comprehensive search process Alison Platt will be appointed as its chair with effect from January 1,…

Chesire-based international veterinary drugs giant Dechra Pharmaceuticals said on Monday its revenue grew 21% to £608 million in the year ended June 30, 2021, and its reported…

Shares of Chesire-based international veterinary drugs giant Dechra Pharmaceuticals rose another 2% on Monday after it published a trading update covering the group’s financial year ended…

Shares of Chesire-based veterinary drugs giant Dechra Pharmaceuticals rose about 4% on Tuesday after it published an update on trading and outlook for the current financial…

Chesire-based veterinary drugs giant Dechra Pharmaceuticals said on Monday its revenue rose 21.8% to £299.8 million and reported profit before tax soared more than 80% to…

Dechra Pharmaceuticals Plc, the Chesire-based veterinary drugs giant, said on Monday it has secured the rights to market Tri-Solfen in Australia and New Zealand and has…

Dechra Pharmaceuticals plc, the Northwich, Chesire-based veterinary drugs giant, said on Wednesday its CEO Ian Page sold 300,000 of his shares in the company at £34.502 per share…

Shares of Dechra Pharmaceuticals Plc, the Northwich, Chesire-based veterinary drugs giant, rose about 7% on Monday after it published results for the year ended June…

Dechra Pharmaceuticals Plc, the Northwich, Chesire-based veterinary drugs giant, said on Thursday it raised £133.4 million by selling just over five million new shares in…

Dechra Pharmaceuticals Plc, the Northwich, Chesire-based veterinary drugs giant, on Wednesday published a trading update for the period from July 1, 2019, to April 30,…

Northwich, Chesire-based veterinary drugs giant Dechra Pharmaceuticals plc said on Tuesday it agreed terms to acquire worldwide rights to the Mirataz product portfolio from Kindred…

Northwich, Chesire-based veterinary drugs giant Dechra Pharmaceuticals Plc said on Monday its revenue rose 7.1% to £248.5 million and profit before tax more than doubled…

Shares of Chesire-based veterinary drugs giant Dechra Pharmaceuticals Plc fell almost 9% on Thursday after it issued a trading update for the half year to…

Chesire-based veterinary drugs giant Dechra Pharmaceuticals Plc said on Monday it agreed terms to acquire the worldwide rights to the Osurnia product portfolio from Elanco Animal…

Chesire-based veterinary drugs giant Dechra Pharmaceuticals Plc said on Monday it changed the ownership of all its UK marketing authorisations to a new unit in…

Manchester-based FTSE 100 firm Auto Trader Group plc, the UK’s largest automotive marketplace, has announced the appointments of two independent non-executive directors to its board. Geeta…

York-based house building giant Persimmon plc said its 2023 profit before tax fell 52% to £352 million as revenues fell 27% to £2.77 billion. Dividend per share is…

Salford-based investment giant AJ Bell said the FTSE 100’s total dividend pay-out, excluding special dividends, is expected to reach £81.8 billion in 2021, a 32%…